Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | ARWR | CYTK | ||
| Company | Halozyme Therapeutic | Arrowhead Pharma | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 64.31 | 55.86 | 60.49 | ||
| High | 64.57 | 56.57 | 61.79 | ||
| Low | 63.22 | 54.02 | 58.43 | ||
| Latest | 63.66 | 55.05 | 60.06 | ||
| Change | +0.10 | +0.04 | +0.06 | ||
| % Change | +0.16% | +0.07% | +0.10% | ||
| Volume | 1,134,100 | 4,477,100 | 1,933,900 | ||
| 20-Day Average Volume | 1,962,645 | 2,372,025 | 1,995,510 | ||
| Previous Close | 63.56 | 55.01 | 60.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 70.00 | 61.97 | 63.95 | ||
| 20-Day Raw Stochastic | 2.41% | 7.84% | 13.63% | ||
| 20-Day Relative Strength | 34.63 | 36.01 | 43.64 | ||
| Weighted Alpha | -0.14 | +187.90 | +13.80 | ||
| Today's Opinion | 8% Sell | 24% Buy | 40% Buy | ||
| Previous Opinion | 8% Sell | 24% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.51% since 03/06/26 | -7.97% since 03/06/26 | -0.58% since 03/06/26 | ||
| Low | 63.22 on 03/13/26 | 54.02 on 03/13/26 | 58.43 on 03/13/26 | ||
| High | 68.40 on 03/10/26 | 60.97 on 03/09/26 | 64.68 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | -19.86% since 02/13/26 | -13.74% since 02/13/26 | -9.36% since 02/13/26 | ||
| Low | 63.22 on 03/13/26 | 54.02 on 03/13/26 | 58.43 on 03/13/26 | ||
| High | 81.51 on 02/17/26 | 67.15 on 03/03/26 | 70.39 on 02/24/26 | ||
| 3-Month | |||||
| %Chg | +2.33% since 12/12/25 | -21.46% since 12/12/25 | -5.19% since 12/12/25 | ||
| Low | 61.69 on 12/15/25 | 54.02 on 03/13/26 | 58.43 on 03/13/26 | ||
| High | 82.22 on 02/09/26 | 76.76 on 01/06/26 | 70.98 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | -17.22% since 09/12/25 | +85.23% since 09/12/25 | +17.47% since 09/12/25 | ||
| Low | 61.22 on 12/11/25 | 28.12 on 09/15/25 | 47.22 on 09/25/25 | ||
| High | 82.22 on 02/09/26 | 76.76 on 01/06/26 | 70.98 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,512,962 | 7,708,761 | 7,397,170 | ||
| Shares Outstanding, K | 118,017 | 140,032 | 123,163 | ||
| Annual Sales | 1,396,610,000 | 829,450,000 | 88,040,000 | ||
| Annual Net Income | 316,890,000 | -1,630,000 | -784,960,000 | ||
| Last Quarter Sales | 451,770,000 | 264,030,000 | 17,760,000 | ||
| Last Quarter Net Income | -141,590,000 | 30,810,000 | -183,030,000 | ||
| 60-Month Beta | 0.98 | 1.23 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 02/17/26 | 0.22 on 02/05/26 | -1.50 on 02/24/26 | ||
| Latest Earnings Date | 05/05/26 | 05/11/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.84 | 35.98 | 0.00 | ||